You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for OTSUKA PHARMACEUTICAL CO., LTD. v. ZYDUS PHARMACEUTICALS USA INC. (D.N.J. 2014)

✉ Email this page to a colleague

« Back to Dashboard

OTSUKA PHARMACEUTICAL CO., LTD. v. ZYDUS PHARMACEUTICALS USA INC. (D.N.J. 2014)

Docket	⤷ Sign Up	Date Filed	2014-05-16
Court	District Court, D. New Jersey	Date Terminated	2017-10-18
Cause	35:271 Patent Infringement	Assigned To	Jerome B. Simandle
Jury Demand	None	Referred To	Karen M. Williams
Parties	OTSUKA PHARMACEUTICAL CO., LTD.
Patents	7,053,092; 8,017,615; 8,580,796; 8,642,600; 8,642,760; 8,759,350
Attorneys	AMY MEGAN HANDLER; TRENT S. DICKEY
Firms	Axinn, Veltrop & Harkrider LLP; Pepper Hamilton LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in OTSUKA PHARMACEUTICAL CO., LTD. v. ZYDUS PHARMACEUTICALS USA INC.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for OTSUKA PHARMACEUTICAL CO., LTD. v. ZYDUS PHARMACEUTICALS USA INC. (D.N.J. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2016-02-18	151		Entry of Summary Judgment Concerning U.S. Patent No. 8,759,350, Certification of Judgment Under Rule 54…2014 18 October 2017 1:14-cv-03168 830 Patent None District Court, D. New Jersey	External link to document
2015-10-13	169		7,053,092 (“the ’092 patent”), 8,017,615 (“the ’615 patent”), 8,580,796 (“the ’796 patent”), 8,…’600 patent”), 8,642,760 (“the ’760 patent”), and 8,759,350 (“the ’350 patent” or the “Patent”). The…drug claimed in a patent or the use of which is claimed in a patent” prior to the patent’s expiration. …various patents covering Otsuka’s brand name aripiprazole product, Abilify®. 1 1 The patents asserted…actions specifically include: U.S. Patent Nos. 5,006,528 (“the ’528 patent”), Case 1:14-cv-03168-JBS-KMW Document	External link to document
2016-02-18	218		Entry of Summary Judgment Concerning U.S. Patent No. 8,759,350, Certification of Judgment Under Rule 54…2014 18 October 2017 1:14-cv-03168 830 Patent None District Court, D. New Jersey	External link to document
2016-04-12	240		5,006,528 (“the ’528 patent”), 7,053,092 (“the ’092 patent”), 8,017,615 (“the ’615 patent”), 8,580,796 (“…(“the ’796 patent”), 8,642,600 (“the ’600 patent”), and 8,642,760 (“the ’760 patent”). …asserted claims of U.S. Patent No. 8,759,350 (hereinafter, “the ’350 patent”), to mean “a single dosage… 1 The patents asserted in these related infringement actions generally include: U.S. Patent Nos. 5,…series of related patents: three directed at Otsuka’s aripiprazole polymorph patents (the ’615, the ’	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.